What is the dosage of Tazverik?

Tazverik is available in 1 dosages, including 200 mg Tab

What is Tazverik made of?

Tazverik contains tazemetostat which is a Methyltransferase Inhibitor

How is Tazverik administered?

Tazverik is administered as a Oral Pill

What is Tazverik mechanism of action?

Tazverik mechanism of action is Multidrug and Toxin Extrusion Transporter 1 Inhibitors, Methyltransferase Inhibitors or Multidrug and Toxin Extrusion Transporter 2 K Inhibitors

Tazverik Prescribing & Dosing Schedule

Dosage & Administration

* Recommended dosage is 800 mg taken orally twice daily with or without food.

Get Your Patient on Tazverik

See your patient's specific prior authorization requirements including coverage restrictions and step therapies

Or select your Insurance from the list below:

Tazverik Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

Tazverik Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program - Only HCP/Speciality Pharmacy Can Enroll

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

EpizymeNOW Enrollment Form

EpizymeNOW Enrollment Form - Online

Enroll in Bridge Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

EpizymeNOW Enrollment Form

EpizymeNOW Enrollment Form - Online

Epizyme Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.